Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 13 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 10 11 12 13 presentations: 1 to 25 of 304
What's New in the Diagnosis and Treatment of Neuroendocrine Tumors
Circulating Biomarkers and Prognosis in Neuroendocrine Tumors
Mark Kidd, PhD
Wren Laboratories, Branford, CT
from ENDO 2018 on March 17, 2018 9:45 AM-11:15 AM
What's New in the Diagnosis and Treatment of Neuroendocrine Tumors
Peptide Receptor Radiotherapy
Wouter W. de Herder, MD,PHD
Erasmus MC, Rotterdam, Netherlands
from ENDO 2018 on March 17, 2018 9:45 AM-11:15 AM
What's New in the Diagnosis and Treatment of Neuroendocrine Tumors
New Avenues for the Treatment of Neuroendocrine Tumors
Marianne Ellen Pavel, MD
Friedrich-Alexander Univ Erlangen-N├╝rnberg, Erlangen, Germany
from ENDO 2018 on March 17, 2018 9:45 AM-11:15 AM
Bone and Cancer: From Basic Mechanisms to Optimizing Patient Care
Bone Disease in Breast Cancer
Catherine Van Poznak, MD
Univ of Michigan, Ann Arbor, MI
from ENDO 2018 on March 17, 2018 4:15 PM-5:45 PM
Bone and Cancer: From Basic Mechanisms to Optimizing Patient Care
Mechanisms, Monitoring and Treatment of Prostate Cancer-Related Bone Disease
Gregory A Clines, MD, PhD
Univ of Michigan, Ann Arbor, MI
from ENDO 2018 on March 17, 2018 4:15 PM-5:45 PM
Bone and Cancer: From Basic Mechanisms to Optimizing Patient Care
Bone Disease in Multiple Myeloma
Suzanne Lentzsch, MD, PhD
Columbia Univ Med Ctr, New York, NY
from ENDO 2018 on March 17, 2018 4:15 PM-5:45 PM
Fueling Cancer: Impact of Metabolic Signals and Manipulating Weight as Therapy
President's Announcements and Awards
Lynnette K. Nieman, MD
President, Endocrine Society, Washington, DC
from ENDO 2018 on March 18, 2018 9:45 AM-11:00 AM
Fueling Cancer: Impact of Metabolic Signals and Manipulating Weight as Therapy
Richard W. Weitzman Outstanding Early Career Invesitgator Award Presented to Gregory Steinberg, PhD
Lynnette K. Nieman, MD
President, Endocrine Society, Washington, DC
from ENDO 2018 on March 18, 2018 9:45 AM-11:00 AM
Fueling Cancer: Impact of Metabolic Signals and Manipulating Weight as Therapy
Outstanding Scholarly Physician Award Presented to Shlomo Melmed, MD
Lynnette K. Nieman, MD
President, Endocrine Society, Washington, DC
from ENDO 2018 on March 18, 2018 9:45 AM-11:00 AM
Fueling Cancer: Impact of Metabolic Signals and Manipulating Weight as Therapy
Outstanding Public Service Award Presented to Irl B. Hirsch, MD
Lynnette K. Nieman, MD
President, Endocrine Society, Washington, DC
from ENDO 2018 on March 18, 2018 9:45 AM-11:00 AM
Fueling Cancer: Impact of Metabolic Signals and Manipulating Weight as Therapy
Metabolic Drivers in Cancer
Lewis C. Cantley, PhD
Weill Cornell Med, New York, NY
from ENDO 2018 on March 18, 2018 9:45 AM-11:00 AM
Fueling Cancer: Impact of Metabolic Signals and Manipulating Weight as Therapy
Using Weight Loss to Beat Cancer
Jennifer A. Ligibel, MD
Dana-Farber Cancer Inst/Harvard Med School, Boston, MA
from ENDO 2018 on March 18, 2018 9:45 AM-11:00 AM
Neuroendocrine Tumors
Neuroendocrine Tumors
Ashley Grossman, MD,FRCP, FMedSci
Royal Free London, London, United Kingdom
from ENDO 2018 on March 18, 2018 9:45 AM-10:30 AM
Medullary Thyroid Carcinoma
Medullary Thyroid Carcinoma
Jaydira Del Rivero, MD
National Cancer Institute/NIH, North Bethesda, MD
from ENDO 2018 on March 18, 2018 1:45 PM-2:30 PM
25 Years of RET Mutations in MEN2: What Have We Learned?
Chair
Gilbert J Cote, PHD
MD Anderson Cancer Ctr, Houston, TX
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
25 Years of RET Mutations in MEN2: What Have We Learned?
How do Activating Mutations of the RET Signaling Pathway Cause Transformation: Therapeutic Implications
Robert F Gagel, MD
MD Anderson Cancer Ctr, Houston, TX
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
25 Years of RET Mutations in MEN2: What Have We Learned?
Balancing Benefits and Risks of Surgical Treatment of Patients with MEN2
Samuel A Wells, MD
Washington Univ Schl of Med, Saint Louis, MO
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
25 Years of RET Mutations in MEN2: What Have We Learned?
What Can We Expect from Targeted Therapy?
Rossella Elisei, MD
Univ of Pisa, Pisa, Italy
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
25 Years of RET Mutations in MEN2: What Have We Learned?
Quality of Life and Coping with MEN2
Ana Oliveira Hoff, MD
ICESP/Univ of Sao Paulo, Sao Paulo, Brazil
from ENDO 2018 on March 20, 2018 11:45 AM-1:15 PM
Challenging Cases from Surgeons and Endocrinologists
A Dilemma of Neuroendocrine Proportion
TK Pandian, MD
Mayo Clinic, Rochester, MN
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
Refractory Cushing's Disease
Andrew J Swearingen, MD
Cleveland Clinic, Cleveland, OH
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
Primary Hyperparathyroidism: A New Diagnostic Pitfall
Kristina Nicholson, MD
University of Pittsburgh, Pittsburgh, PA
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
A Case of Rapidly Progressive Thyroid Carcinoma with Rare and Unexpected Pathology
Hunter J Underwood, MD
NYU Langone Medical Center, New York, NY
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
A 74 Year-old Male with Endocrinological Eye Exam
Alexander L Shifrin, MD
Jersey Shore University Medical Center, Neptune, NJ
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
Challenging Cases from Surgeons and Endocrinologists
High Pressure Decision Points
Philip W Smith, MD
University of Virginia, Charlottesville, VA
from ENDO 2017 on April 3, 2017 2:30 PM-4:15 PM
<< first | < prev page: of 13 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 10 11 12 13 presentations: 1 to 25 of 304